SVB Wealth’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-49,761
Closed -$4.94M 671
2019
Q3
$4.94M Sell
49,761
-4,272
-8% -$406K 0.1% 132
2019
Q2
$5M Sell
54,033
-1,942
-3% -$184K 0.17% 130
2019
Q1
$5.28M Sell
55,975
-81,516
-59% -$7.13M 0.21% 98
2018
Q4
$8.81M Sell
137,491
-81,711
-37% -$6.03M 0.38% 79
2018
Q3
$19.6M Buy
219,202
+646
+0.3% +$57.1K 0.69% 46
2018
Q2
$17.4M Sell
218,556
-34,846
-14% -$2.89M 0.67% 48
2018
Q1
$22.6M Sell
253,402
-13,578
-5% -$1.3M 0.87% 37
2017
Q4
$27.9M Sell
266,980
-11,023
-4% -$1.24M 1.05% 25
2017
Q3
$40.5M Buy
278,003
+1,944
+0.7% +$265K 1.56% 7
2017
Q2
$35.9M Sell
276,059
-1,443
-0.5% -$177K 1.41% 9
2017
Q1
$34.5M Sell
277,502
-4,760
-2% -$570K 1.38% 9
2016
Q4
$32.7M Buy
282,262
+32,619
+13% +$3.63M 1.35% 10
2016
Q3
$26.1M Buy
249,643
+20,178
+9% +$2.18M 1.06% 20
2016
Q2
$22.6M Sell
229,465
-12,558
-5% -$1.3M 0.92% 27
2016
Q1
$24.2M Sell
242,023
-4,660
-2% -$480K 0.99% 23
2015
Q4
$29.5M Sell
246,683
-8,028
-3% -$929K 1.17% 17
2015
Q3
$27.6M Sell
254,711
-15,862
-6% -$1.97M 1.07% 19
2015
Q2
$31.3M Buy
270,573
+4,012
+2% +$459K 1.04% 23
2015
Q1
$30.7M Sell
266,561
-2,705
-1% -$323K 0.99% 21
2014
Q4
$30.1M Buy
+269,266
New +$28.4M 0.97% 22

Other funds holding CELG

SVB Wealth's CELG Position: Q4 2019 in Review

SVB Wealth sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 49,761 shares — an estimated $4.94M sold.

SVB Wealth first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $40.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SVB Wealth reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SVB Wealth sold 49,761 Celgene Corp shares in Q4 2019, an estimated $4.94M.
  • SVB Wealth first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • SVB Wealth's Celgene Corp position peaked at $40.5M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SVB Wealth's 13F filing for Q4 2019, filed 13 Feb 2020.